A Pharmacokinetic Study of Pemetrexed in the Cerebrospinal Fluid of Patients with cancer or Leptomeningeal Metastases.
Active, no longer recruiting
Phase of Trial: Phase 0
Latest Information Update: 20 Jun 2018
At a glance
- Drugs Pemetrexed (Primary) ; Pemetrexed (Primary)
- Indications Cancer metastases; Haematological malignancies; Lymphoma; Solid tumours
- Focus Biomarker; Pharmacokinetics; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 13 Jun 2018 Planned primary completion date changed from 1 Mar 2018 to 1 Mar 2019.
- 15 Mar 2017 Planned End Date changed from 1 Mar 2016 to 1 Mar 2020.